| Epigenetics in cancer stem cells TB Toh, JJ Lim, EKH Chow Molecular cancer 16, 1-20, 2017 | 388 | 2017 |
| Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells X Wang, XC Low, W Hou, LN Abdullah, TB Toh, M Mohd Abdul Rashid, ... ACS nano 8 (12), 12151-12166, 2014 | 212 | 2014 |
| Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy Y Zhao, TWH Shuen, TB Toh, XY Chan, M Liu, SY Tan, Y Fan, H Yang, ... Gut, gutjnl-2017-315201, 2018 | 164 | 2018 |
| Nanodiamond–mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells TB Toh, DK Lee, W Hou, LN Abdullah, J Nguyen, D Ho, EKH Chow Molecular pharmaceutics 11 (8), 2683-2691, 2014 | 115 | 2014 |
| Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma TB Toh, JJ Lim, L Hooi, MBMA Rashid, EKH Chow Journal of hepatology 72 (1), 104-118, 2020 | 111 | 2020 |
| Epigenetics of hepatocellular carcinoma TB Toh, JJ Lim, EKH Chow Clinical and translational medicine 8 (1), 13, 2019 | 99 | 2019 |
| Applications of stimuli-responsive nanoscale drug delivery systems in translational research M Gu, X Wang, TB Toh, EKH Chow Drug Discovery Today 23 (5), 1043-1052, 2018 | 97 | 2018 |
| JAK/STAT signaling in hepatocellular carcinoma JJ Hin Tang, DK Hao Thng, JJ Lim, TB Toh Hepatic oncology 7 (1), HEP18, 2020 | 95 | 2020 |
| Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP) MBMA Rashid, TB Toh, L Hooi, A Silva, Y Zhang, PF Tan, AL Teh, ... Science translational medicine 10 (453), eaan0941, 2018 | 88 | 2018 |
| Dual‐targeting dual‐action platinum (IV) platform for enhanced anticancer activity and reduced nephrotoxicity MV Babak, Y Zhi, B Czarny, TB Toh, L Hooi, EKH Chow, WH Ang, ... Angewandte Chemie International Edition 58 (24), 8109-8114, 2019 | 84 | 2019 |
| Cryopreservation of neurospheres derived from human glioblastoma multiforme YK Chong, TB Toh, N Zaiden, A Poonepalli, SH Leong, CEL Ong, Y Yu, ... Stem cells 27 (1), 29-39, 2009 | 82 | 2009 |
| Generation of Matched Patient-Derived Xenograft In Vitro-In Vivo Models Using 3D Macroporous Hydrogels for the Study of Liver Cancer ELS Fong, TB Toh, X Lin, Z Liu, L Hooi, MBMA Rashid, T Benoukraf, ... Biomaterials, 2018 | 69 | 2018 |
| ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis YK Chong, E Sandanaraj, LWH Koh, M Thangaveloo, MSY Tan, GRH Koh, ... Journal of the National Cancer Institute 108 (2), djv326, 2016 | 68 | 2016 |
| A flexi‐PEGDA upconversion implant for wireless brain photodynamic therapy DBL Teh, A Bansal, C Chai, TB Toh, RAJ Tucker, GGL Gammad, Y Yeo, ... Advanced Materials 32 (29), 2001459, 2020 | 66 | 2020 |
| 3D culture as a clinically relevant model for personalized medicine ELS Fong, TB Toh, H Yu, EKH Chow SLAS TECHNOLOGY: Translating Life Sciences Innovation 22 (3), 245-253, 2017 | 59 | 2017 |
| Nanodiamond–Manganese dual mode MRI contrast agents for enhanced liver tumor detection W Hou, TB Toh, LN Abdullah, TWZ Yvonne, KJ Lee, I Guenther, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (3), 783-793, 2017 | 57 | 2017 |
| New high-throughput screening identifies compounds that reduce viability specifically in liver cancer cells that express high levels of SALL4 by inhibiting oxidative … JL Tan, F Li, JZ Yeo, KJ Yong, MA Bassal, GH Ng, MY Lee, CY Leong, ... Gastroenterology 157 (6), 1615-1629. e17, 2019 | 47 | 2019 |
| Stimuli-responsive nanodiamond-based biosensor for enhanced metastatic tumor site detection X Wang, M Gu, TB Toh, NLB Abdullah, EKH Chow SLAS TECHNOLOGY: Translating Life Sciences Innovation 23 (1), 44-56, 2018 | 43 | 2018 |
| Identification and optimization of combinatorial glucose metabolism inhibitors in hepatocellular carcinomas MB Mohd Abdul Rashid, TB Toh, A Silva, L Nurrul Abdullah, CM Ho, D Ho, ... Journal of laboratory automation 20 (4), 423-437, 2015 | 43 | 2015 |
| Capitalizing on synthetic lethality of MYC to treat cancer in the digital age DKH Thng, TB Toh, EKH Chow Trends in pharmacological sciences 42 (3), 166-182, 2021 | 42 | 2021 |
